Twist Bioscience Corporation (TWST)
Nasdaq: TWST · Biological Products, (No Diagnostic Substances) · South San Francisco, CA · filing with the SEC since 2013
Filings
283 filings since 2017 beside 1,352 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026Due nextLarge accelerated filer
10-K
Annual report for the fiscal year ending Sep 30, 2026Large accelerated filers have 60 days after the fiscal year ends.
by Nov 29, 2026
10-Q
Quarterly report for the quarter ending Dec 31, 2026Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by Feb 9, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Jan 6, 2026.
Filings a yearinsider forms included
84140231139157251284282
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 4 times in the last 36 months, the newest Aug 6, 2025.SEC letters: 3 in the last 36 months, the newest Mar 5, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Aug 5, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Aug 4, 2026
Feb 17, 2026
8-K items 3.02, 8.01, 9.01
Shares sold without registration; Other event · Current report
Feb 11, 2026
40 of 283 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.